Mechanism of Shenqi Dihuangtang in Blocking Renal Fibrosis Injury in Diabetic Kidney Disease Mediated by Epithelial-mesenchymal Transition Through Inhibiting TGF-β1/Smad Signaling Axis
|更新时间:2026-03-03
|
Mechanism of Shenqi Dihuangtang in Blocking Renal Fibrosis Injury in Diabetic Kidney Disease Mediated by Epithelial-mesenchymal Transition Through Inhibiting TGF-β1/Smad Signaling Axis
增强出版
“Shenqi Dihuang Decoction has made progress in the treatment of diabetes kidney disease. Through network pharmacology and in vivo experiments, experts have identified its active ingredients and mechanism of action, providing new ideas for the treatment of DKD.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 32, Issue 7, Pages: 32-45(2026)
LIU Liangjing,LIU Haolan,MAO Xiaoling,et al.Mechanism of Shenqi Dihuangtang in Blocking Renal Fibrosis Injury in Diabetic Kidney Disease Mediated by Epithelial-mesenchymal Transition Through Inhibiting TGF-β1/Smad Signaling Axis[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(07):32-45.
LIU Liangjing,LIU Haolan,MAO Xiaoling,et al.Mechanism of Shenqi Dihuangtang in Blocking Renal Fibrosis Injury in Diabetic Kidney Disease Mediated by Epithelial-mesenchymal Transition Through Inhibiting TGF-β1/Smad Signaling Axis[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(07):32-45. DOI: 10.13422/j.cnki.syfjx.20260114.
Mechanism of Shenqi Dihuangtang in Blocking Renal Fibrosis Injury in Diabetic Kidney Disease Mediated by Epithelial-mesenchymal Transition Through Inhibiting TGF-β1/Smad Signaling Axis增强出版
Diabetic Kidney Disease and Gut-kidney Axis: A Review
Mechanisms of Bushen Tongluo Jiangzhuo Prescription in Improving Renal Fibrosis in Rats with Chronic Kidney Disease Based on PI3K/Akt/mTOR Signaling Pathway
Qishao Capsules Improve Diabetic Renal Injury in db/db Mice by Inhibiting Podocyte Apoptosis via Regulating Caspase-8 and Caspase-3
Mechanism of Huazhuo Jiedu Prescription in Alleviating Renal Fibrosis in 5/6 Nephrectomy Rats Based on AMPK/mTOR Pathway
Related Author
WANG Yingchao
CHEN Yexin
ZHANG Hua
LIU Jiangteng
RUAN Zhichao
PAN Xingru
HUANG Weijun
ZHAO Jinxi
Related Institution
Dongzhimen Hospital, Beijing University of Chinese Medicine
Beijing Aerospace General Hospital
Mukogawa Women's University, Hyogo Prefecture
Dongzhimen Hospital, Beijing University of Chinese Medicine
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University